Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 3 Comparison of the demographic and disease characteristics between RA patients with/without HF within the normal range according to patient-reported outcomes (MHQ and DASH)

From: Patient and physician perspectives of hand function in a cohort of rheumatoid arthritis patients: the impact of disease activity

Characteristics MHQ-NR, N = 76 MHQ below NR, N = 63 DASH-NR, N = 114 DASH above NR, N = 25 p1/p2
Female gender, N° (%) 65 (85.5) 59 (93.7) 99 (86.8) 25 (100) 0.17/0.07
Age at hand function evaluationa 42.7 ± 12.6 45.7 ± 13.6 42.5 ± 13.4 51.2 ± 8.8 0.18/0.002
Years of scholarshipa 11.4 ± 3.6 10.5 ± 4 11.2 ± 3.7 10.1 ± 4.4 0.15/0.19
Disease duration, yearsb 7.5 (3–10) 6 (2–9) 7 (3–10) 4 (0–8) 0.17/0.007
N° (%) of patients with RF 63 (82.9) 57 (90.5) 97 (85.1) 23 (92) 0.22/0.53
N° (%) of patients with ACCP 69 (90.8) 56 (90.3) 102 (90.3) 23 (92) 1/1
DAS28b 1.5 (1–2.1) 3 (1.8–4.5) 1.7 (1.1–2.4) 4.4 (3–6) 0.000/0.00
N° (%) of patients with erosions 29 (38.2) 26 (41.3) 46 (40.4) 9 (36) 0.73/0.82
N° of comorbidities/patientb 2 (1–3) 1 (1–3) 2 (1–3) 2 (1–4) 0.55/0.56
N° (%) of patients with corticosteroids 41 (53.9) 39 (61.9) 64 (56.1) 16 (64) 0.39/0.51
N° of DMARDs/patientb 1 (1–2) 2 (2–2) 2 (1–2) 2 (2–2) 0.000/0.02
  1. RF rheumatoid factor, ACCP antibodies to cyclic citrullinated peptides, MHQ Michigan Hand Outcome Questionnaire, DASH Disabilities of the Arm, Shoulder and Hand Outcome Measure, NR normal range, p1 MHQ-NR score vs. MHQ score below NR, and p2 DASH-NR score vs. DASH score above NR
  2. aMean ± SD
  3. bMedian (Q25-Q75)